List of Attending Speakers | 2024
- Mira Chaurushiya, Managing Director, Westlake Village BioPartners
- John Connolly, Chief Scientific Officer, Parker Institute for Cancer Immunology; Iterim CEO, 3T Biosciences
- Richard DiMarchi, Professor, Indiana University
- Dalton Einhorn, Global Head of Pharmaceutical Corporate Venture Capital, Asahi Kasei Pharma
- Jason Hafler, Managing Director, Sanofi Ventures
- Richard Heyman, Executive Chairman, Metacrine
- Rachna Khosla, Senior Vice President, Business Development, Amgen
- Stuart Mackey, Global Head of Business Development, Daiichi Sankyo
- Mathai Mammen, CEO, President and Chairman, FogPharma
- Peter Meinke, Sanders Director, Tri-Institutional Therapeutics Discovery Institute, Inc’
- Detlev Mennerich, Corporate SVP, Global Head of Business Development & Licensing, Boehringer Ingelheim
- Carole Nuechterlein, Head, Roche Venture Fund
- Emma Parmee, Global Head Therapeutics Discovery, The Janssen Pharmaceutical Companies of Johnson and Johnson
- Sunil Patel, Senior Vice President & Head of Corporate Development, Merck
- Jeremy Quirk, VP BD&L Commercial Portfolio, GSK
- Uwe Schoenbeck, Senior Vice President and CSO, Emerging Science and Innovation (ES&I), Pfizer Worldwide Research and Development and Medical, Pfizer
- Peter Schultz, Scripps Family Chair Professor, President and CEO, Department of Chemistry, Scripps Research
- Andy Schwab, Founder & Managing Partner, 5AM Ventures
- Tari Suprapto, Director, Search & Evaluation (West), Novo Nordisk
*As of August 30th, 2023